Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
Cancer Research
|
July 26, 2000
HER-2/neu is a tumor rejection target in tolerized HER-2/neu transgenic mice
R T Reilly, M B Gottlieb, A M Ercolini, et al.
The Cancer Journal From Scientific American
|
June 5, 1998
Development and characterization of a cytokine-secreting pancreatic adenocarcinoma vaccine from primary tumors for use in clinical trials
E M Jaffee, M Schutte, J Gossett, et al.
Human Gene Therapy
|
March 1, 1995
Phase I study of non-replicating autologous tumor cell injections using cells prepared with or without GM-CSF gene transduction in patients with metastatic renal cell carcinoma
A J Berns, S Clift, L K Cohen, et al.
The Journal of Urology
|
March 1, 1994
Demonstration of a rational strategy for human prostate cancer gene therapy
M G Sanda, S R Ayyagari, E M Jaffee, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
August 5, 2000
Intracranial paracrine interleukin-2 therapy stimulates prolonged antitumor immunity that extends outside the central nervous system
M G Ewend, R C Thompson, R Anderson, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 3, 1996
The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product
A Y Huang, P H Gulden, A S Woods, et al.
Gene Therapy
|
July 5, 2001
Improved gene transfer efficiency to primary and established human pancreatic carcinoma target cells via epidermal growth factor receptor and integrin-targeted adenoviral vectors
J G Wesseling, P J Bosma, V Krasnykh, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 10, 2000
Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival
A Chakravarthy, R A Abrams, C J Yeo, et al.
Cancer Research
|
June 5, 2001
Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma
P Argani, C Rosty, R E Reiter, et al.
Human Gene Therapy
|
September 19, 1998
A phase I clinical trial of lethally irradiated allogeneic pancreatic tumor cells transfected with the GM-CSF gene for the treatment of pancreatic adenocarcinoma
E M Jaffee, R Abrams, J Cameron, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
Cancer Research
|
July 26, 2000
HER-2/neu is a tumor rejection target in tolerized HER-2/neu transgenic mice
R T Reilly, M B Gottlieb, A M Ercolini, et al.
The Cancer Journal From Scientific American
|
June 5, 1998
Development and characterization of a cytokine-secreting pancreatic adenocarcinoma vaccine from primary tumors for use in clinical trials
E M Jaffee, M Schutte, J Gossett, et al.
Human Gene Therapy
|
March 1, 1995
Phase I study of non-replicating autologous tumor cell injections using cells prepared with or without GM-CSF gene transduction in patients with metastatic renal cell carcinoma
A J Berns, S Clift, L K Cohen, et al.
The Journal of Urology
|
March 1, 1994
Demonstration of a rational strategy for human prostate cancer gene therapy
M G Sanda, S R Ayyagari, E M Jaffee, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
August 5, 2000
Intracranial paracrine interleukin-2 therapy stimulates prolonged antitumor immunity that extends outside the central nervous system
M G Ewend, R C Thompson, R Anderson, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 3, 1996
The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product
A Y Huang, P H Gulden, A S Woods, et al.
Gene Therapy
|
July 5, 2001
Improved gene transfer efficiency to primary and established human pancreatic carcinoma target cells via epidermal growth factor receptor and integrin-targeted adenoviral vectors
J G Wesseling, P J Bosma, V Krasnykh, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 10, 2000
Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival
A Chakravarthy, R A Abrams, C J Yeo, et al.
Cancer Research
|
June 5, 2001
Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma
P Argani, C Rosty, R E Reiter, et al.
Human Gene Therapy
|
September 19, 1998
A phase I clinical trial of lethally irradiated allogeneic pancreatic tumor cells transfected with the GM-CSF gene for the treatment of pancreatic adenocarcinoma
E M Jaffee, R Abrams, J Cameron, et al.
Page
of 5